Selected research
Market Outlook & Growth Opportunities
Global Cell Engineering Service Market Outlook and Growth Opportunities 2026
Market perspective
The global Cell Engineering Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Cell Engineering Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Cell Engineering Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Cell Engineering Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Cell Engineering Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Cell Engineering Service market include Portal Biotechnologies, Lonza Group, Thermo Fisher Scientific, Sartorius, GenScript, Metagenomi, CorrectSequence Therapeutics and Eddie Gene, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Cell Engineering Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Cell Engineering Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Cell Engineering Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Cell Engineering Service market.
Cell Engineering Service Segment by Company
Portal Biotechnologies
Lonza Group
Thermo Fisher Scientific
Sartorius
GenScript
Metagenomi
CorrectSequence Therapeutics
Eddie Gene
Cell Engineering Service Segment by Type
Gene Editing
Cell Line Development
Others
Cell Engineering Service Segment by Application
Medical Industry
Scientific Research
Others
Cell Engineering Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Cell Engineering Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Cell Engineering Service key companies, revenue, market share, and recent developments.
3. To split the Cell Engineering Service breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Cell Engineering Service market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Cell Engineering Service significant trends, drivers, influence factors in global and regions.
6. To analyze Cell Engineering Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell Engineering Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cell Engineering Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell Engineering Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cell Engineering Service industry.
Chapter 3: Detailed analysis of Cell Engineering Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Cell Engineering Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Cell Engineering Service in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Gene Editing
- Cell Line Development
- Others
Applications
- Medical Industry
- Scientific Research
- Others
Companies covered
- Portal Biotechnologies
- Lonza Group
- Thermo Fisher Scientific
- Sartorius
- GenScript
- Metagenomi
- CorrectSequence Therapeutics
- Eddie Gene
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Cell Engineering Service Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Cell Engineering Service Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Cell Engineering Service Market Dynamics
- 2.1 Cell Engineering Service Industry Trends
- 2.2 Cell Engineering Service Industry Drivers
- 2.3 Cell Engineering Service Industry Opportunities and Challenges
- 2.4 Cell Engineering Service Industry Restraints
3 Cell Engineering Service Market by Company
- 3.1 Global Cell Engineering Service Company Revenue Ranking in 2025
- 3.2 Global Cell Engineering Service Revenue by Company (2021-2026)
- 3.3 Global Cell Engineering Service Company Ranking (2024-2026)
- 3.4 Global Cell Engineering Service Company Manufacturing Base and Headquarters
- 3.5 Global Cell Engineering Service Company Product Type and Application
- 3.6 Global Cell Engineering Service Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Cell Engineering Service Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Cell Engineering Service Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Cell Engineering Service Market by Type
- 4.1 Cell Engineering Service Type Introduction
- 4.1.1 Gene Editing
- 4.1.2 Cell Line Development
- 4.1.3 Others
- 4.2 Global Cell Engineering Service Sales Value by Type
- 4.2.1 Global Cell Engineering Service Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Cell Engineering Service Sales Value by Type (2021-2032)
- 4.2.3 Global Cell Engineering Service Sales Value Share by Type (2021-2032)
5 Cell Engineering Service Market by Application
- 5.1 Cell Engineering Service Application Introduction
- 5.1.1 Medical Industry
- 5.1.2 Scientific Research
- 5.1.3 Others
- 5.2 Global Cell Engineering Service Sales Value by Application
- 5.2.1 Global Cell Engineering Service Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Cell Engineering Service Sales Value by Application (2021-2032)
- 5.2.3 Global Cell Engineering Service Sales Value Share by Application (2021-2032)
6 Cell Engineering Service Regional Value Analysis
- 6.1 Global Cell Engineering Service Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Cell Engineering Service Sales Value by Region (2021-2032)
- 6.2.1 Global Cell Engineering Service Sales Value by Region: 2021-2026
- 6.2.2 Global Cell Engineering Service Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Cell Engineering Service Sales Value (2021-2032)
- 6.3.2 North America Cell Engineering Service Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Cell Engineering Service Sales Value (2021-2032)
- 6.4.2 Europe Cell Engineering Service Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Cell Engineering Service Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Cell Engineering Service Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Cell Engineering Service Sales Value (2021-2032)
- 6.6.2 South America Cell Engineering Service Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Cell Engineering Service Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Cell Engineering Service Sales Value Share by Country, 2025 VS 2032
7 Cell Engineering Service Country-level Value Analysis
- 7.1 Global Cell Engineering Service Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Cell Engineering Service Sales Value by Country (2021-2032)
- 7.2.1 Global Cell Engineering Service Sales Value by Country (2021-2026)
- 7.2.2 Global Cell Engineering Service Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Cell Engineering Service Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Cell Engineering Service Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Cell Engineering Service Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Cell Engineering Service Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Cell Engineering Service Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Cell Engineering Service Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Cell Engineering Service Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Cell Engineering Service Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Cell Engineering Service Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Cell Engineering Service Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Cell Engineering Service Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Cell Engineering Service Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Cell Engineering Service Sales Value Growth Rate (2021-2032)
- 7.7.2 France Cell Engineering Service Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Cell Engineering Service Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Cell Engineering Service Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Cell Engineering Service Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Cell Engineering Service Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Cell Engineering Service Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Cell Engineering Service Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Cell Engineering Service Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Cell Engineering Service Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Cell Engineering Service Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Cell Engineering Service Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Cell Engineering Service Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Cell Engineering Service Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Cell Engineering Service Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Cell Engineering Service Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Cell Engineering Service Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Cell Engineering Service Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Cell Engineering Service Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Cell Engineering Service Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Cell Engineering Service Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Cell Engineering Service Sales Value Growth Rate (2021-2032)
- 7.14.2 China Cell Engineering Service Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Cell Engineering Service Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Cell Engineering Service Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Cell Engineering Service Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Cell Engineering Service Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Cell Engineering Service Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Cell Engineering Service Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Cell Engineering Service Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Cell Engineering Service Sales Value Growth Rate (2021-2032)
- 7.17.2 India Cell Engineering Service Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Cell Engineering Service Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Cell Engineering Service Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Cell Engineering Service Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Cell Engineering Service Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Cell Engineering Service Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Cell Engineering Service Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Cell Engineering Service Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Cell Engineering Service Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Cell Engineering Service Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Cell Engineering Service Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Cell Engineering Service Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Cell Engineering Service Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Cell Engineering Service Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Cell Engineering Service Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Cell Engineering Service Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Cell Engineering Service Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Cell Engineering Service Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Cell Engineering Service Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Cell Engineering Service Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Cell Engineering Service Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Cell Engineering Service Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Cell Engineering Service Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Cell Engineering Service Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Cell Engineering Service Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Cell Engineering Service Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Cell Engineering Service Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Cell Engineering Service Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Cell Engineering Service Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Cell Engineering Service Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Cell Engineering Service Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Cell Engineering Service Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Cell Engineering Service Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Cell Engineering Service Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Cell Engineering Service Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Cell Engineering Service Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Cell Engineering Service Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Cell Engineering Service Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Cell Engineering Service Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Cell Engineering Service Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Cell Engineering Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Portal Biotechnologies
- 8.1.1 Portal Biotechnologies Company Information
- 8.1.2 Portal Biotechnologies Business Overview
- 8.1.3 Portal Biotechnologies Cell Engineering Service Revenue and Gross Margin (2021-2026)
- 8.1.4 Portal Biotechnologies Cell Engineering Service Product Portfolio
- 8.1.5 Portal Biotechnologies Recent Developments
- 8.2 Lonza Group
- 8.2.1 Lonza Group Company Information
- 8.2.2 Lonza Group Business Overview
- 8.2.3 Lonza Group Cell Engineering Service Revenue and Gross Margin (2021-2026)
- 8.2.4 Lonza Group Cell Engineering Service Product Portfolio
- 8.2.5 Lonza Group Recent Developments
- 8.3 Thermo Fisher Scientific
- 8.3.1 Thermo Fisher Scientific Company Information
- 8.3.2 Thermo Fisher Scientific Business Overview
- 8.3.3 Thermo Fisher Scientific Cell Engineering Service Revenue and Gross Margin (2021-2026)
- 8.3.4 Thermo Fisher Scientific Cell Engineering Service Product Portfolio
- 8.3.5 Thermo Fisher Scientific Recent Developments
- 8.4 Sartorius
- 8.4.1 Sartorius Company Information
- 8.4.2 Sartorius Business Overview
- 8.4.3 Sartorius Cell Engineering Service Revenue and Gross Margin (2021-2026)
- 8.4.4 Sartorius Cell Engineering Service Product Portfolio
- 8.4.5 Sartorius Recent Developments
- 8.5 GenScript
- 8.5.1 GenScript Company Information
- 8.5.2 GenScript Business Overview
- 8.5.3 GenScript Cell Engineering Service Revenue and Gross Margin (2021-2026)
- 8.5.4 GenScript Cell Engineering Service Product Portfolio
- 8.5.5 GenScript Recent Developments
- 8.6 Metagenomi
- 8.6.1 Metagenomi Company Information
- 8.6.2 Metagenomi Business Overview
- 8.6.3 Metagenomi Cell Engineering Service Revenue and Gross Margin (2021-2026)
- 8.6.4 Metagenomi Cell Engineering Service Product Portfolio
- 8.6.5 Metagenomi Recent Developments
- 8.7 CorrectSequence Therapeutics
- 8.7.1 CorrectSequence Therapeutics Company Information
- 8.7.2 CorrectSequence Therapeutics Business Overview
- 8.7.3 CorrectSequence Therapeutics Cell Engineering Service Revenue and Gross Margin (2021-2026)
- 8.7.4 CorrectSequence Therapeutics Cell Engineering Service Product Portfolio
- 8.7.5 CorrectSequence Therapeutics Recent Developments
- 8.8 Eddie Gene
- 8.8.1 Eddie Gene Company Information
- 8.8.2 Eddie Gene Business Overview
- 8.8.3 Eddie Gene Cell Engineering Service Revenue and Gross Margin (2021-2026)
- 8.8.4 Eddie Gene Cell Engineering Service Product Portfolio
- 8.8.5 Eddie Gene Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst